Setmelanotide
Long Term Extension Trial of Setmelanotide
Rhythm · Phase 2/3 · Completed · Enrollment 205
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Setmelanotide | n/r | n/r | n/r | n/r |
Not shown
- Setmelanotide: endpoint not reported